Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing GoBroad Hospital, Beijing, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia · Acute Promyelocytic Leukemia With PML-RARA

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Ziftomenib Maintenance Post Allo-HCT

Acute Myeloid Leukemia · Acute Myeloid Leukemia in Remission · NPM1 Mutation

Abroad (travel likely)RecruitingPHASE1

Boston, United States · Columbus, United States

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Non-Hodgkin Lymphoma · Chronic Lymphocytic Leukemia · Acute Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE1

Houston, United States · Houston, United States